• HOME
  • PRODUCTS
    • BioSan
    • BioSera
    • CovaLab S.A.S. antibodies, kits and reagents
    • GenScript products
    • GoldenGate BioScience
    • Sarstedt, TPP and Biocentrix plastic wares
    • UDG molecular biology kits and reagents
      • Protein kits and reagents
      • Nucleic acid electrophoresis and blotting
      • Nucleic acid purification technologies
      • PCR & RT-PCR kits and reagents
      • Chemicals
      • Vectors and cloning kits
  • WEBSHOP
  • SERVICES
    • Clinical genomics services
    • Functional genomics services ►
      • Capillary sequencing and fragment analysis
      • NGS - New Generation Sequencing
      • Real Time PCR
      • Epigenetics: MEDIP; ChIP-Seq.
    • Bioinformatics ►
      • Data analysis/mining
      • Integrated database generation
    • Agrigenomics
    • Antibody related services
    • Proteomics
    • Biobanking
  • R&D PROJECTS
    • Genomic biomarker identification and companion diagnostics development
    • SCHIZO project
    • Immunoprecipitation kit development
    • Targeted ex-vivo gene therapy to treat AMD
    • Tear proteomic depletion kit development
    • Micro RNA measuring with UPL based technique
    • The Commercialisation of Transglutaminase
    • Antitest termelő sejtvonal fejlesztés
  • REFERENCES
    • Our partners
    • Publications
  • ABOUT US
    • UD-GenoMed introduction
    • Grants
    • Aims of UDG
    • Career
    • Quality Management System
    • 2018-1.1.2-KFI-2018-00172
  • CONTACT US
  • Hun
  • Eng

R&D Projects

Since our establishment we participated several R&D projects with the primary goal to create added values that contribute to the development of our products and services portfolio. Based on our innovation strategy we have been collaborating from basic research to product development with our partners.
There is a close collaboration between our company and several research groups especially the Clinical Genomics Center of the University of Debrecen. Finding new partnerships e.g. in the frames of the new Calls of Horizon2020 R&D programme is a priority for us as well.

Genomic biomarker identification, companion diagnostics development
The objective of our project panel is to identify gene expression biomarkers from patient blood samples that can predict patient responsiveness to the recommended treatment.
SCHIZO project
The aim of the project is to develop biomarkers and methods to support, rationalize and accelerate the discovery and development of novel drugs for the treatment of psychotic disorders.
Immunoprecipitation control kit development
Our aim was to develop the prototype of kits adaptable in tumour genetics based on epigenetic measurements. Within this project we could eventually patent a universal control system for immunoprecipitation that is a proprietary platform technology with a wide application field including antibody drug development and antibody drug serum level monitoring.
Targeted ex-vivo gene therapy to treat AMD
The purpose of TargetAMD FP7 project is to develop such a transposon-based targeted ex-vivo method which aims the treatment of age related macular degeneration.
Tear proteomic depletion kit development
The objective of this project was develop a depletion kit prototype for diagnosis of diabetes complications.
miRNA measurement with UPL-based technique
The objective and the result of our experiments were the set up of a universal RT-QPCR method. The design software required for the method is provided open access.
The commercialization of TG2 enzyme
The overall objective of the TRANSCOM and TRANSPATH FP7 projects is to establish the molecular nature of the role of the multifunctional enzymes transglutaminases in the pathogenesis of diseases which are known to involve their cross-linking activity.
 

 

 

Contacts

 

UD-GenoMed Medical Genomic Technologies Ltd.

University of Debrecen, Medical and Health Science Center

4032 Debrecen, Hungary, Nagyerdei krt. 98.
Theoretical Building Room 211.
Office (direct no.): +36-52-314-372
Phone: +36-52-411-717 (ext. 54616)
Email: info@ud-genomed.hu

Chief Executive Officer: Dr. János Kádas.

Mobile: +36-70-327-9896
Email: kadas.janos@ud-genomed.hu